Der Report
Verifizierte Nachrichten zu Finanzierung, Hauptsitzen und Führungskräften der innovativsten Unternehmen der Welt
83 Berichte und es werden mehr
Rein Security Raises $25M Series A for AI Agent Runtime Security
Rein Security raised a $25 million Series A co-led by Glilot Capital and Sienna Venture Capital for its platform that secures enterprise AI agents at runtime.
Wally Raises $25M Series A for Subscription Dental Care
Wally announced $25 million in Series A funding led by Maveron and says it plans to expand from 15 to 100 locations by the end of 2027.
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Footprint Raises $25M Series B for AI-Native Risk Operations
Footprint raised a $25 million Series B led by QED Investors to scale its AI operating system for financial-crime risk and compliance.
Solstice Oncology Raises $225M Series A for Neoadjuvant Immuno-Oncology
Solstice Oncology launched with a $225 million Series A led by RA Capital Management to advance porustobart, a neoadjuvant immuno-oncology therapy.
iPronics Raises $125M Series B for Optical AI Networking
iPronics raised a $125 million Series B co-led by Maverick Silicon and Light Street Capital to scale optical networking for AI data centers.
Thyme Care Closes $125M+ Series E and Establishes Thyme Companies
Thyme Care raised more than $125 million in a Series E led by Morgan Health at a valuation of more than $2 billion and established Thyme Companies to build new oncology businesses.
Arintra Raises $25M Series B for Healthcare Revenue Assurance
Arintra raised a $25 million Series B led by Define Ventures, bringing total funding to $51 million for its autonomous medical-coding platform.
Renata Medical Raises $25M Series D for Pediatric Cardiovascular Devices
Renata Medical raised a $25 million Series D led by ARCHIMED to expand U.S. commercialization of its Minima Stent System and advance pediatric heart disease technologies.
9 Berichte angezeigt • Seite 1 • Kategorie: all
Bleiben Sie dem Markt voraus
Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.